Derma Sciences (DSCI) Misses Q1 EPS by 14c

Derma Sciences (NASDAQ: DSCI) reported Q1 EPS of ($0.46), $0.14 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $19.8 million versus the consensus estimate of $19.79 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell